1-13 of 13
Kendall Diebold
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Refined genetic risk model with complex karyotype predicts outcomes of newly diagnosed acute myeloid leukemia treated with decitabine plus venetoclax

Free
Razan Mohty, Kendall Diebold, Todd Mudd, Maris Hardee, Jay Jarodiya, Katherine Parks, Kimo Bachiashvili, Manuel Espinoza-Gutarra, Sravanti Rangaraju, Pankit Vachhani, Omer Jamy
Journal: Blood
Blood (2025) 146 (Supplement 1): 5272.
https://doi.org/10.1182/blood-2025-5272
Published: 2025
Journal Articles

Choice of hypomethylating agent for newly diagnosed TP53-mutant Acute Myeloid Leukemia: A command registry study

Free
Talha Badar, Omer Jamy, Chenyu Lin, Anand Patel, Yu-Hung Wang, Rory Shallis, Kendall Diebold, Alex Coltoff, Aaron Goldberg, Jan Philipp Bewersdorf, Kenneth Zabel, Charles Foucar, Yasmin Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Adam Duvall, Vamsi Kota, Shyam Patel, Amer Zeidan, Ehab Atallah, Mark Litzow
Journal: Blood
Blood (2025) 146 (Supplement 1): 874.
https://doi.org/10.1182/blood-2025-874
Published: 2025
Journal Articles

Changing burden of Acute Myeloid Leukemia in the United States: A 23-year national analysis

Free
Qais Bin Abdul Ghaffar, Kendall Diebold, Omer Jamy
Journal: Blood
Blood (2025) 146 (Supplement 1): 6399.
https://doi.org/10.1182/blood-2025-6399
Published: 2025
Journal Articles

Dosing variability of tyrosine kinase inhibitors in chronic myeloid leukemia

Free
Joshua Knapp, Kendall Diebold, Devan Parker, Sarah Worth, Manuel Espinoza-Gutarra, Pankit Vachhani, Kimo Bachiashvili, Sravanti Rangaraju, Razan Mohty, Jorge Cortes, Ravi Bhatia, Omer Jamy
Journal: Blood
Blood (2025) 146 (Supplement 1): 6398.
https://doi.org/10.1182/blood-2025-6398
Published: 2025
Journal Articles

Improved outcomes with higher cumulative doses of cytarabine consolidation in older patients with acute myeloid leukemia

Free
Todd Mudd, Kendall Diebold, Sravanti Rangaraju, Kimo Bachiashvili, Pankit Vachhani, Manuel Espinoza-Gutarra, Razan Mohty, Ravi Bhatia, Omer Jamy
Journal: Blood
Blood (2025) 146 (Supplement 1): 5220.
https://doi.org/10.1182/blood-2025-5220
Published: 2025
Journal Articles

Improved outcomes with low-dose hypomethylating agent plus venetoclax as post-transplant maintenance in patients undergoing reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for myeloid malignancies

Free
Kendall Diebold, Todd Mudd, Maris Hardee, Haley Thigpen, Manuel Espinoza-Gutarra, Antonio Di Stasi, Donna Salzman, Razan Mohty, Ravi Bhatia, Omer Jamy
Journal: Blood
Blood (2025) 146 (Supplement 1): 4261.
https://doi.org/10.1182/blood-2025-4261
Published: 2025
Journal Articles

Superior Survival with Intensive Chemotherapy, Compared to Hypomethylating Agent + Venetoclax, in Patients with Intermediate/Adverse Risk Acute Myeloid Leukemia Unable to Proceed to Transplant

Free
Kendall Diebold, Todd Mudd, Jay Jarodiya, Katherine Parks, Maris Hardee, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Manuel Espinoza-Gutarra, Razan Mohty, Ravi Bhatia, Omer Jamy
Journal: Blood
Blood (2024) 144 (Supplement 1): 2900.
https://doi.org/10.1182/blood-2024-204120
Published: 2024
Journal Articles

Effect of Lumbar Puncture Timing on Neurotoxicity with Blinatumomab Therapy in a Real-World Cohort of Acute Lymphoblastic Leukemia (ALL)

Free
Sravanti Rangaraju, Kendall Diebold, Pankit Vachhani, Omer Jamy, Kimo Bachiashvili, Ravi Bhatia, Razan Mohty, Manuel Espinoza-Gutarra, Joshua Oliver, Barry Diamond, Kaitlin Moulton, Zaid Al-Kadhimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 2808.
https://doi.org/10.1182/blood-2024-211985
Published: 2024
Journal Articles

Low-Dose Decitabine Plus Venetoclax As Post-Transplant Maintenance for High-Risk Myeloid Malignancies

Free
Katherine Parks, Kendall Diebold, Donna Salzman, Antonio Di Stasi, Manuel Espinoza-Gutarra, Ravi Bhatia, Zaid Al-Kadhimi, Omer Jamy
Journal: Blood
Blood (2023) 142 (Supplement 1): 7052.
https://doi.org/10.1182/blood-2023-184658
Published: 2023
Journal Articles

Real-World Evidence of Treatment-Free Remission in Chronic Myeloid Leukemia at an Academic Center in the Deep South

Free
Greg Bascug, Garrett Bourne, Kendall Diebold, Joshua Knapp, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Ravi Bhatia, Omer Jamy
Journal: Blood
Blood (2023) 142 (Supplement 1): 7425.
https://doi.org/10.1182/blood-2023-184757
Published: 2023
Journal Articles

Idarubicin and Cytarabine with and without Midostaurin for FLT3-Mutated Acute Myeloid Leukemia

Free
Kendall Diebold, Sarah Worth, Kimo Bachiashvili, Pankit Vachhani, Sravanti Rangaraju, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Ravi Bhatia, Omer Jamy
Journal: Blood
Blood (2023) 142 (Supplement 1): 5910.
https://doi.org/10.1182/blood-2023-185198
Published: 2023
Journal Articles

Addition of Single Dose Gemtuzumab Ozogamicin to Intensive Induction Chemotherapy in Core-Binding Factor Acute Myeloid Leukemia

Free
Garrett Bourne, Kendall Diebold, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Ravi Bhatia, Omer Jamy
Journal: Blood
Blood (2023) 142 (Supplement 1): 5848.
https://doi.org/10.1182/blood-2023-189853
Published: 2023
Journal Articles

Optimal Induction and Consolidation Strategy for Patients with Complex Karyotype and TP53 -Mutated Acute Myeloid Leukemia

Free
Omer H Jamy, Kendall Diebold, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Kelly N. Godby, Donna Salzman, Ravi Bhatia
Journal: Blood
Blood (2022) 140 (Supplement 1): 8959–8960.
https://doi.org/10.1182/blood-2022-160346
Published: 2022